Optimization of the sulforhodamine B colorimetric assay
- 1 October 1997
- journal article
- Published by Elsevier BV in Journal of Immunological Methods
- Vol. 208 (2), 151-158
- https://doi.org/10.1016/s0022-1759(97)00137-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- P-glycoprotein Binding and Modulation of the Multidrug-Resistant Phenotype by EstramustineJNCI Journal of the National Cancer Institute, 1994
- A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell linesEuropean Journal of Cancer, 1993
- Colorimetric chemosensitivity testing using sulforhodamine BJournal of Surgical Oncology, 1993
- Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testingEuropean Journal of Cancer and Clinical Oncology, 1991
- Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell LinesJNCI Journal of the National Cancer Institute, 1991
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell LinesJNCI Journal of the National Cancer Institute, 1990
- Drug Discovery Screen Adapts to ChangesJNCI Journal of the National Cancer Institute, 1990
- The synthesis of XTT: A new tetrazolium reagent that is bioreducible to a water‐soluble formazanJournal of Heterocyclic Chemistry, 1988
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983